Skip to main content
Log in

A comparative study of combined treatment with fractional carbon dioxide and targeted ultraviolet B phototherapy for facial vitiligo

  • Original Article
  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

Facial vitiligo is associated with considerable psychological impact. The management is challenging and requires multidisciplinary treatment. Adding fractional carbon dioxide (CO2) to the conventional treatment has been reported as an effective modality. This study aimed to evaluate the efficacy of combined fractional CO2 laser, targeted ultraviolet B (UVB) phototherapy, and topical steroid on facial vitiligo. A prospective, randomized, split face study was conducted on 14 patients with symmetrical non-segmental facial vitiligo. Ten sessions of fractional CO2 laser was performed on the lesions on one side of face with 2-week interval. Immediately after laser, the lesions on both side of face were treated with 10 sessions of 2-week interval targeted UVB phototherapy and twice daily application of topical 0.05 % clobetasol propionate cream. The patients were followed up for 12 weeks after the last treatment. Clinical improvement was graded by blinded dermatologists and patients using a quartile grading scale. Twelve out of 14 patients completed the study. The degree of improvement was not different between both sides in nine patients. One patient showed more improvement on the combined laser side, and two patients showed inferior results on the combined laser side. Two patients with lesser improvement on the laser-treated side had positive Koebner phenomenon on the non-facial area. The combined treatment with laser, targeted UVB, and topical steroids are not superior to targeted UVB and topical steroids in facial vitiligo. Furthermore, laser may retard the response to the standard treatment in patients with Koebner phenomenon on non-treated areas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V (2011) Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 65:473–491. doi:10.1016/j.jaad.2010.11.061

    Article  PubMed  Google Scholar 

  2. Chan MF, Thng TG, Aw CW, Goh BK, Lee SM, Chua TL (2013) Investigating factors associated with quality of life of vitiligo patients in Singapore. Int J Nurs Pract 19(Suppl 3):3–10. doi:10.1111/ijn.12179

    Article  PubMed  Google Scholar 

  3. Parsad D, Pandhi R, Dogra S, Kanwar AJ, Kumar B (2003) Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol 148:373–374, PMID: 12588405

    Article  CAS  PubMed  Google Scholar 

  4. Ingordo V, Cazzaniga S, Gentile C, Iannazzone SS, Cusano F, Naldi L (2012) Dermatology Life Quality Index score in vitiligo patients: a pilot study among young Italian males. G Ital Dermatol Venereol 147:83–90, PMID: 22370571

    CAS  PubMed  Google Scholar 

  5. Akdeniz N, Yavuz IH, GunesBilgili S, OzaydinYavuz G, Calka O (2014) Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo. J Dermatolog Treat 25:196–199. doi:10.3109/09546634.2013.777381

    Article  CAS  PubMed  Google Scholar 

  6. Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S (2009) The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial. J Dermatolog Treat 20:14–18. doi:10.1080/09546630802155057

    Article  CAS  PubMed  Google Scholar 

  7. Sassi F, Cazzaniga S, Tessari G, Chatenoud L, Reseghetti A, Marchesi L, Girolomoni G, Naldi L (2008) Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck. Br J Dermatol 159:1186–1191. doi:10.1111/j.1365-2133.2008.08793.x

    CAS  PubMed  Google Scholar 

  8. Bayoumi W, Fontas E, Sillard L, Le Duff F, Ortonne JP, Bahadoran P, Lacour JP, Passeron T (2012) Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations. Br J Dermatol 166:208–211. doi:10.1111/j.1365-2133.2011.10564.x

    Article  CAS  PubMed  Google Scholar 

  9. Shin J, Lee JS, Hann SK, Oh SH (2012) Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study. Br J Dermatol 166:658–661. doi:10.1111/j.1365-2133.2011.10723.x

    Article  CAS  PubMed  Google Scholar 

  10. Vachiramon V, Chaiyabutr C, Rattanaumpawan P, Kanokrungsee S (2016) Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas. Lasers Surg Med 48:197–202. doi:10.1002/lsm.22389

    Article  PubMed  Google Scholar 

  11. Li L, Wu Y, Li L, Sun Y, Qiu L, Gao XH, Chen HD (2015) Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B for refractory vitiligo: a prospective, randomized half-body, comparative study. Dermatol Ther 28:131–134. doi:10.1111/dth.12202

    Article  PubMed  Google Scholar 

  12. Mohamed HA, Mohammed GF, Gomaa AH, Eyada MM (2015) Carbon dioxide laser plus topical 5-fluorouracil: a new combination therapeutic modality for acral vitiligo. J Cosmet Laser Ther 17:216–223. doi:10.3109/14764172.2014.1003241

    Article  PubMed  Google Scholar 

  13. Anbar TS, Westerhof W, Abdel-Rahman AT, Ewis AA, El-Khayyat MA (2008) Effect of one session of ER:YAG laser ablation plus topical 5 Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study. Photodermatol Photoimmunol Photomed 24:322–329. doi:10.1111/j.1600-0781.2008.00385.x

    Article  PubMed  Google Scholar 

  14. Nicolaidou E, Antoniou C, Stratigos AJ, Stefanaki C, Katsambas AD (2007) Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy. J Am Acad Dermatol 56:274–278, PMID: 17224369

    Article  PubMed  Google Scholar 

  15. Welsh O, Herz-Ruelas ME, Gomez M, Ocampo-Candiani J (2009) Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area. Int J Dermatol 48:529–534. doi:10.1111/j.1365-4632.2009.03928.x

    Article  PubMed  Google Scholar 

  16. van Geel N, Speeckaert R, De Wolf J, Bracke S, Chevolet I, Brochez L, Lambert J (2012) Clinical significance of Koebner phenomenon in vitiligo. Br J Dermatol 167:1017–1024. doi:10.1111/j.1365-2133.2012.11158.x

    Article  PubMed  Google Scholar 

  17. Akar A, Tunca M, Koc E, Kurumlu Z (2009) Broadband targeted UVB phototherapy for localized vitiligo: a retrospective study. Photodermatol Photoimmunol Photomed 25:161–163. doi:10.1111/j.1600-0781.2009.00426.x

    Article  PubMed  Google Scholar 

  18. Hadi SM, Spencer JM, Lebwohl M (2004) The use of the 308-nm excimer laser for the treatment of vitiligo. Dermatol Surg 30:983–986, PMID: 15209787

    PubMed  Google Scholar 

  19. Brazzelli V, Antoninetti M, Palazzini S, Barbagallo T, De Silvestri A, Borroni G (2007) Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy. J Eur Acad Dermatol Venereol 21:1369–1374, PMID: 17958843

    Article  CAS  PubMed  Google Scholar 

  20. Newman MD, Silverberg NB (2011) Once-daily application of calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment for repigmentation of facial vitiligo. Cutis 88:256–259, PMID: 22272490

    PubMed  Google Scholar 

  21. Helou J, Maatouk I, Obeid G, Moutran R, Stephan F, Tomb R (2014) Fractional laser for vitiligo treated by 10,600 nm ablative fractional carbon dioxide laser followed by sun exposure. Lasers Surg Med 46:443–448. doi:10.1002/lsm.22260

    Article  CAS  PubMed  Google Scholar 

  22. Anbar TS, Westerhof W, Abdel-Rahman AT, El-Khayyat MA (2006) Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites. Photodermatol Photoimmunol Photomed 22:157–163, PMID: 16719871

    Article  CAS  PubMed  Google Scholar 

  23. Hallaji Z, Ghiasi M, Eisazadeh A, Damavandi MR (2012) Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy. Photodermatol Photoimmunol Photomed 28:115–119. doi:10.1111/j.1600-0781.2012.00648.x

    Article  PubMed  Google Scholar 

  24. Alhowaish AK, Dietrich N, Onder M, Fritz K (2013) Effectiveness of a 308-nm excimer laser in treatment of vitiligo: a review. Lasers Med Sci 28:1035–1041. doi:10.1007/s10103-012-1185-1

    Article  PubMed  Google Scholar 

  25. Taieb A, Alomar A, Bohm M et al (2013) Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol 168:5–19. doi:10.1111/j.1365-2133.2012.11197.x

    Article  CAS  PubMed  Google Scholar 

  26. Felsten LM, Alikhan A, Petronic-Rosic V (2011) Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment. J Am Acad Dermatol 65:493–514. doi:10.1016/j.jaad.2010.10.043

    Article  PubMed  Google Scholar 

  27. Hofer A, Hassan AS, Legat FJ, Kerl H, Wolf P (2005) Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients. Br J Dermatol 152:981–985, PMID: 15888156

    Article  CAS  PubMed  Google Scholar 

  28. Shen Z, Gao TW, Chen L, Yang L, Wang YC, Sun LC, Li CY, Xiao Y, Liu YF (2007) Optimal frequency of treatment with the 308-nm excimer laser for vitiligo on the face and neck. Photomed Laser Surg 25:418–427, PMID: 17975956

    Article  CAS  PubMed  Google Scholar 

  29. Ho N, Pope E, Weinstein M, Greenberg S, Webster C, Krafchik BR (2011) A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo. Br J Dermatol 165:626–632. doi:10.1111/j.1365-2133.2011.10351.x

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vasanop Vachiramon.

Ethics declarations

Funding/support

Funding/support came from the Dermatological Society of Thailand.

Role of the sponsors

None.

Conflict of interest

We have no conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kanokrungsee, S., Chanprapaph, K., Chaiyabutr, C. et al. A comparative study of combined treatment with fractional carbon dioxide and targeted ultraviolet B phototherapy for facial vitiligo. Lasers Med Sci 31, 1343–1349 (2016). https://doi.org/10.1007/s10103-016-1982-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10103-016-1982-z

Keywords

Navigation